For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has ADC Therapeutics SA (ADCT) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
ADC Therapeutics SA is one of 889 individual stocks in the Medical sector. Collectively, these companies sit at #6 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. ADC Therapeutics SA is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ADCT's full-year earnings has moved 34.3% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the latest available data, ADCT has gained about 7.1% so far this year. Meanwhile, stocks in the Medical group have lost about 7.2% on average. As we can see, ADC Therapeutics SA is performing better than its sector in the calendar year.
Bioventus (BVS) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 32.7%.
For Bioventus, the consensus EPS estimate for the current year has increased 55.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, ADC Therapeutics SA belongs to the Medical - Biomedical and Genetics industry, which includes 433 individual stocks and currently sits at #146 in the Zacks Industry Rank. This group has lost an average of 1.2% so far this year, so ADCT is performing better in this area.
On the other hand, Bioventus belongs to the Medical - Drugs industry. This 133-stock industry is currently ranked #94. The industry has moved -1.1% year to date.
Investors interested in the Medical sector may want to keep a close eye on ADC Therapeutics SA and Bioventus as they attempt to continue their solid performance.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.
See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ADC Therapeutics SA (ADCT): Free Stock Analysis Report
Bioventus Inc. (BVS): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).